Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany. Acousia has the expertise to identify small molecules for treatment of hearing loss.

Sensory hair cells are the key cells for hearing in the inner ear. Acousia`s approach will help to replace lost hair cells by cellular regeneration originating from supporting cells.

ASpherecousia will develop drugs for local application, which will restore hearing in patients who have lost their hearing ability due to various reasons, e.g. noise trauma, treatment with ototoxic drugs or sudden deafness. In addition, this therapy will have the potential to treat the age-related decrease in hearing capacity.